Back to Search Start Over

Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer.

Authors :
Qidong Zhou
Weihong Ding
Zhiyu Qian
Quangang Zhu
Chuanyu Sun
Qin Yu
Zongguang Tai
Ke Xu
Source :
Molecular Pharmaceutics; 11/1/2021, Vol. 18 Issue 11, p4015-4028, 14p
Publication Year :
2021

Details

Language :
English
ISSN :
15438384
Volume :
18
Issue :
11
Database :
Supplemental Index
Journal :
Molecular Pharmaceutics
Publication Type :
Academic Journal
Accession number :
156281124
Full Text :
https://doi.org/10.1021/acs.molpharmaceut.1c00448